Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,711.50
Bid: 1,710.50
Ask: 1,711.50
Change: 6.50 (0.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,713.00
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks rise but markets cautious ahead of Fed decision

Wed, 30th Apr 2014 11:53

- Markets cautious ahead of FOMC outcome- Eurozone inflation picks up but misses consensus- Heritage Oil jumps on takeover offer- Shell and Tullow lead markets highertechMARK 2,775.59 -0.56%FTSE 100 6,776.83 +0.10%FTSE 250 15,813.39 -0.52%UK stocks were trading slightly higher on Wednesday but were rangebound in morning trade after markets hit an eight-week high the previous session.A raft of economic data and corporate earnings were keep traders busy today, while nervousness ahead of this evening's policy decision by the Federal Reserve prompted many to scale back risk.The Federal Open Market Committee begun its two-day policy meeting yesterday and is widely expected to continue tapering its asset purchase programme by $10bn each meeting. This will bring the monthly stock of bond buying down from $55bn to $45bn."It's very unlikely that they'd change this amount or announce anything different when there's no accompanying press conference. It would cause unnecessary panic in the markets, which the Fed has tried to avoid when possible," said Market Analyst Craig Erlam from Alpari.The FTSE 100 was trading 0.1% higher at 6,777 by midday after closing at 6,769.91 on Tuesday afternoon, its highest finish since March 6th.In economic news this morning, Eurozone inflation rose less than expected in April, according to the flash estimate published this morning by Eurostat. The annual rate of consumer price inflation rose to 0.7% this month after prices rose by 0.5% in March. However, this compared to the consensus estimate for a 0.8% rise. US stock futures were pointing to a lower start on Wall Street later on ahead of upcoming mortgage applications data and the ADP employment report, as well as a reading of US economic growth for the first quarter. Heritage Oil jumps after takeover offerHeritage Oil shares surged this morning after Energy Investments Global offer 320p a share to take over the company, some 25% above yesterday's closing price. The offer values the company at £924m. Heritage also announced today that profits more than doubled in 2013.Oil major Royal Dutch Shell rose strongly despite saying that first-quarter underlying earnings fell by 3%, which exclude £2.9bn of impairments in its Downstream division.Sector peer Tullow also gained after saying it is on track to meet its 2014 production guidance following a good performance since the start of the year.Rolls-Royce, the power systems group, was also higher after confirming media speculation that it is in talks with German engineer Siemens about the possible sale of its energy gas turbine and compressor division.High street retail giant Next was swinging between gains and losses despite lifting its guidance for sales and profits this year after a strong performance in the first quarter. The company also announced that it would pay a special dividend and raise the limit of its share buyback.Heading the other way was insurer Standard Life after underwhelming with a 1.5% rise in assets under administration in the first quarter.GlaxoSmithKline was in the red despite meeting expectations with a 2% rise in constant-currency core earnings per share to 21p. Revenues however declined by 2% to £5.6bn.Admiral fell after going ex-dividend, along with others including ITV, Croda, Cobham, G4S, Ferrexpo, Tesco, Reed Elsevier, Travis Perkins and Weir.FTSE 100 - RisersRoyal Dutch Shell 'B' (RDSB) 2,547.00p +4.77%Royal Dutch Shell 'A' (RDSA) 2,372.50p +4.06%Barratt Developments (BDEV) 364.50p +3.76%WPP (WPP) 1,264.00p +2.27%Capita (CPI) 1,076.00p +1.99%Tullow Oil (TLW) 881.00p +1.79%Rolls-Royce Holdings (RR.) 1,039.00p +1.76%BG Group (BG.) 1,199.50p +1.61%Severn Trent (SVT) 1,853.00p +1.59%Shire Plc (SHP) 3,299.00p +1.10%FTSE 100 - FallersAdmiral Group (ADM) 1,390.00p -3.61%Tesco (TSCO) 293.05p -3.38%Hargreaves Lansdown (HL.) 1,161.00p -2.19%Reed Elsevier (REL) 864.50p -2.10%British American Tobacco (BATS) 3,415.00p -2.06%William Hill (WMH) 340.10p -2.04%GlaxoSmithKline (GSK) 1,632.00p -2.01%ITV (ITV) 180.00p -2.01%Imperial Tobacco Group (IMT) 2,556.00p -1.88%Weir Group (WEIR) 2,679.00p -1.83%FTSE 250 - RisersHeritage Oil (HOIL) 313.40p +22.61%Aveva Group (AVV) 2,097.00p +7.26%Ophir Energy (OPHR) 265.00p +5.49%Afren (AFR) 159.00p +3.72%Playtech (PTEC) 654.50p +2.51%Cairn Energy (CNE) 183.70p +1.94%Bellway (BWY) 1,424.00p +1.79%Premier Oil (PMO) 343.00p +1.72%Taylor Wimpey (TW.) 104.10p +1.46%Soco International (SIA) 424.30p +1.39%FTSE 250 - FallersCSR (CSR) 604.00p -5.85%Supergroup (SGP) 1,317.00p -4.08%UBM (UBM) 646.00p -3.94%Hunting (HTG) 850.00p -3.57%SIG (SHI) 192.00p -3.57%Kazakhmys (KAZ) 228.60p -3.54%Elementis (ELM) 275.70p -3.47%Petra Diamonds Ltd.(DI) (PDL) 162.20p -3.45%IP Group (IPO) 174.10p -3.28%Cranswick (CWK) 1,197.00p -3.23%BC
More News
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.